Theravance Biopharma Inc (TBPH)
Total Costs & Expenses
$21.34M
Quarterly · Period ending: · USD
TBPH Total Costs & Expenses
Latest reported$21.34Mperiod ending
Latest reported$21.34Mperiod ending
TBPH Quarterly Total Costs & Expenses (-$32.60M → $21.34M)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
TBPH total costs & expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 21,335,000 | |
| 23,549,000 | |
| 28,326,000 | |
| 26,445,000 | |
| 28,920,000 | |
| 29,822,000 | |
| 27,954,000 | |
| 27,705,000 | |
| 29,961,000 | |
| 25,710,000 | |
| 23,805,000 | |
| 24,453,000 | |
| 29,872,000 | |
| 35,329,000 | |
| 32,080,000 | |
| 26,653,000 | |
| 34,151,000 | |
| 50,419,000 | |
| 71,113,000 | |
| 66,809,000 | |
| 77,024,000 | |
| 98,149,000 | |
| 95,220,000 | |
| 94,872,000 | |
| 87,184,000 | |
| 92,338,000 | |
| 100,071,000 | |
| 77,628,000 | |
| 68,626,000 | |
| 79,004,000 | |
| 78,358,000 | |
| 75,288,000 | |
| 72,180,000 | |
| 73,295,000 | |
| 83,691,000 | |
| 61,272,000 | |
| 68,630,000 | |
| 61,916,000 | |
| 63,525,000 | |
| 52,569,000 | |
| 52,968,000 | |
| 60,052,000 | |
| 59,667,000 | |
| 53,793,000 | |
| 52,427,000 | |
| 58,138,000 | |
| 67,186,000 | |
| 56,398,000 | |
| 59,680,000 | |
| 60,963,000 | |
| 44,255,000 | |
| 41,102,000 | |
| 38,957,000 | |
| 32,196,000 | |
| 167,948,000 | |
| -32,595,000 |